VVOS
VVOS
NASDAQ · Health Care

Vivos Therapeutics Inc

$0.13
-0.01 (-4.69%)
As of Sep 28, 10:38 PM ET ·
Financial Highlights (FY 2026)
Revenue
53.76M
Net Income
-65,252,809
Gross Margin
60.4%
Profit Margin
-121.4%
Rev Growth
+2.9%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 60.4% 60.4% 46.4% 46.4%
Operating Margin -114.0% -102.6% 21.5% 19.1%
Profit Margin -121.4% -115.3% 15.3% 15.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 53.76M 52.26M 4.42M 4.57M
Gross Profit 32.49M 31.59M 2.05M 2.12M
Operating Income -61,317,908 -53,641,249 949.1K 872.8K
Net Income -65,252,809 -57,083,522 675.6K 727.9K
Gross Margin 60.4% 60.4% 46.4% 46.4%
Operating Margin -114.0% -102.6% 21.5% 19.1%
Profit Margin -121.4% -115.3% 15.3% 15.9%
Rev Growth +2.9% +2.9% +3.6% -1.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 6.54M 5.85M
Total Equity — — 8.58M 7.69M
D/E Ratio — — 0.76 0.76
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -57,285,417 -52,897,692 1.16M 1.26M
Free Cash Flow — — 869.0K 665.9K